Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,171,379
-$9,499,623 QoQ
Shares Held
1,591,030
-28.6% QoQ
Ownership
1.90%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TORONTO DOMINION BANK holds $906,007,871 across 49 Biotechnology names. REPL ranks #15 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
3,025,963 | $206,158,858 | |
| 2 | STOK |
Stoke Therapeutics, Inc.
|
3,173,258 | $103,321,280 | |
| 3 | CELC |
Celcuity Inc.
|
882,758 | $100,757,998 | |
| 4 | IMTX |
Immatics N.V.
|
7,436,342 | $73,173,605 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
130,460 | $68,291,895 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,236,436 | $49,741,820 | |
| 7 | URGN |
UroGen Pharma Ltd.
|
2,616,714 | $47,048,517 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
781,800 | $41,216,496 |
All Filings in REPL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,171,379 | 1,591,030 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,671,002 | 2,229,527 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,748,897 | 1,372,052 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||